{"entity":{"type":"insider","cik":"0001868517","url":"/insider/0001868517","json_url":"/insider/0001868517.json","name":"Morisset Valerie","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":7,"first":"2024-07-03","last":"2024-07-23","span_basis":"filed_date"},"name_variants":[{"name":"Morisset Valerie","source":"filing","n_filings":7,"first_seen":"2024-07-03","last_seen":"2024-07-23"}],"transactions":[{"id":2070272,"accession":"0001415889-24-019946","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001415889-24-019946","line_url":"/filing/0001415889-24-019946","is_derivative":false,"issuer_cik":"0001768446","issuer_name":"Eliem Therapeutics, Inc.","issuer_ticker":"ELYM","issuer_name_source":null,"issuer_url":"/issuer/0001768446","owner_cik":"0001868517","owner_name":"Morisset Valerie","owner_display_name":"Morisset Valerie","owner_url":"/insider/0001868517","role":"Officer (EVP, R&D AND CSO)","role_mark":"O","role_mark_label":"Officer (EVP, R&D AND CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D AND CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":69005.0,"shares_display":"69,005","price_per_share":8.030872400550685,"price_display":"8.03","price_state":"stated","total_value":554170.35,"total_display":"554,170.35","total_whole":"554,170","shares_owned_after":61317.0,"shares_owned_after_display":"61,317","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-22","filed_date":"2024-07-23","scope":"insider","n_lines":2},{"id":2070269,"accession":"0001415889-24-019946","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-019946","line_url":"/filing/0001415889-24-019946","is_derivative":false,"issuer_cik":"0001768446","issuer_name":"Eliem Therapeutics, Inc.","issuer_ticker":"ELYM","issuer_name_source":null,"issuer_url":"/issuer/0001768446","owner_cik":"0001868517","owner_name":"Morisset Valerie","owner_display_name":"Morisset Valerie","owner_url":"/insider/0001868517","role":"Officer (EVP, R&D AND CSO)","role_mark":"O","role_mark_label":"Officer (EVP, R&D AND CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D AND CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60201.0,"shares_display":"60,201","price_per_share":7.2145826481287685,"price_display":"7.21","price_state":"stated","total_value":434325.09,"total_display":"434,325.09","total_whole":"434,325","shares_owned_after":100322.0,"shares_owned_after_display":"100,322","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-19","filed_date":"2024-07-23","scope":"insider","n_lines":2},{"id":2043899,"accession":"0001415889-24-019814","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-019814","line_url":"/filing/0001415889-24-019814#line-2","is_derivative":false,"issuer_cik":"0001768446","issuer_name":"Eliem Therapeutics, Inc.","issuer_ticker":"ELYM","issuer_name_source":null,"issuer_url":"/issuer/0001768446","owner_cik":"0001868517","owner_name":"Morisset Valerie","owner_display_name":"Morisset Valerie","owner_url":"/insider/0001868517","role":"Officer (EVP, R&D AND CSO)","role_mark":"O","role_mark_label":"Officer (EVP, R&D AND CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D AND CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38576.0,"shares_display":"38,576","price_per_share":6.93,"price_display":"6.93","price_state":"stated","total_value":267331.68,"total_display":"267,331.68","total_whole":"267,332","shares_owned_after":160523.0,"shares_owned_after_display":"160,523","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-18","filed_date":"2024-07-19","scope":"insider"},{"id":2043897,"accession":"0001415889-24-019814","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-019814","line_url":"/filing/0001415889-24-019814#line-1","is_derivative":false,"issuer_cik":"0001768446","issuer_name":"Eliem Therapeutics, Inc.","issuer_ticker":"ELYM","issuer_name_source":null,"issuer_url":"/issuer/0001768446","owner_cik":"0001868517","owner_name":"Morisset Valerie","owner_display_name":"Morisset Valerie","owner_url":"/insider/0001868517","role":"Officer (EVP, R&D AND CSO)","role_mark":"O","role_mark_label":"Officer (EVP, R&D AND CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D AND CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3207.0,"shares_display":"3,207","price_per_share":6.91,"price_display":"6.91","price_state":"stated","total_value":22160.37,"total_display":"22,160.37","total_whole":"22,160","shares_owned_after":199099.0,"shares_owned_after_display":"199,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-17","filed_date":"2024-07-19","scope":"insider"},{"id":2564442,"accession":"0001415889-24-019706","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-019706","line_url":"/filing/0001415889-24-019706#line-1","is_derivative":false,"issuer_cik":"0001768446","issuer_name":"Eliem Therapeutics, Inc.","issuer_ticker":"ELYM","issuer_name_source":null,"issuer_url":"/issuer/0001768446","owner_cik":"0001868517","owner_name":"Morisset Valerie","owner_display_name":"Morisset Valerie","owner_url":"/insider/0001868517","role":"Officer (EVP, R&D AND CSO)","role_mark":"O","role_mark_label":"Officer (EVP, R&D AND CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D AND CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":7.13,"price_display":"7.13","price_state":"stated","total_value":356500.0,"total_display":"356,500.00","total_whole":"356,500","shares_owned_after":202306.0,"shares_owned_after_display":"202,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-16","filed_date":"2024-07-17","scope":"insider"},{"id":3142434,"accession":"0001415889-24-019610","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-019610","line_url":"/filing/0001415889-24-019610#line-2","is_derivative":false,"issuer_cik":"0001768446","issuer_name":"Eliem Therapeutics, Inc.","issuer_ticker":"ELYM","issuer_name_source":null,"issuer_url":"/issuer/0001768446","owner_cik":"0001868517","owner_name":"Morisset Valerie","owner_display_name":"Morisset Valerie","owner_url":"/insider/0001868517","role":"Officer (EVP, R&D AND CSO)","role_mark":"O","role_mark_label":"Officer (EVP, R&D AND CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D AND CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42377.0,"shares_display":"42,377","price_per_share":7.01,"price_display":"7.01","price_state":"stated","total_value":297062.77,"total_display":"297,062.77","total_whole":"297,063","shares_owned_after":252306.0,"shares_owned_after_display":"252,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-15","filed_date":"2024-07-16","scope":"insider"},{"id":3142429,"accession":"0001415889-24-019610","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-019610","line_url":"/filing/0001415889-24-019610#line-1","is_derivative":false,"issuer_cik":"0001768446","issuer_name":"Eliem Therapeutics, Inc.","issuer_ticker":"ELYM","issuer_name_source":null,"issuer_url":"/issuer/0001768446","owner_cik":"0001868517","owner_name":"Morisset Valerie","owner_display_name":"Morisset Valerie","owner_url":"/insider/0001868517","role":"Officer (EVP, R&D AND CSO)","role_mark":"O","role_mark_label":"Officer (EVP, R&D AND CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D AND CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":7.07,"price_display":"7.07","price_state":"stated","total_value":353500.0,"total_display":"353,500.00","total_whole":"353,500","shares_owned_after":294683.0,"shares_owned_after_display":"294,683","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-12","filed_date":"2024-07-16","scope":"insider"},{"id":2391905,"accession":"0001415889-24-019504","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-019504","line_url":"/filing/0001415889-24-019504#line-3","is_derivative":false,"issuer_cik":"0001768446","issuer_name":"Eliem Therapeutics, Inc.","issuer_ticker":"ELYM","issuer_name_source":null,"issuer_url":"/issuer/0001768446","owner_cik":"0001868517","owner_name":"Morisset Valerie","owner_display_name":"Morisset Valerie","owner_url":"/insider/0001868517","role":"Officer (EVP, R&D AND CSO)","role_mark":"O","role_mark_label":"Officer (EVP, R&D AND CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D AND CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":7.11,"price_display":"7.11","price_state":"stated","total_value":355500.0,"total_display":"355,500.00","total_whole":"355,500","shares_owned_after":344683.0,"shares_owned_after_display":"344,683","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-11","filed_date":"2024-07-11","scope":"insider"},{"id":2391900,"accession":"0001415889-24-019504","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-019504","line_url":"/filing/0001415889-24-019504#line-2","is_derivative":false,"issuer_cik":"0001768446","issuer_name":"Eliem Therapeutics, Inc.","issuer_ticker":"ELYM","issuer_name_source":null,"issuer_url":"/issuer/0001768446","owner_cik":"0001868517","owner_name":"Morisset Valerie","owner_display_name":"Morisset Valerie","owner_url":"/insider/0001868517","role":"Officer (EVP, R&D AND CSO)","role_mark":"O","role_mark_label":"Officer (EVP, R&D AND CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D AND CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":6.83,"price_display":"6.83","price_state":"stated","total_value":341500.0,"total_display":"341,500.00","total_whole":"341,500","shares_owned_after":394683.0,"shares_owned_after_display":"394,683","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-10","filed_date":"2024-07-11","scope":"insider"},{"id":2391898,"accession":"0001415889-24-019504","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-019504","line_url":"/filing/0001415889-24-019504#line-1","is_derivative":false,"issuer_cik":"0001768446","issuer_name":"Eliem Therapeutics, Inc.","issuer_ticker":"ELYM","issuer_name_source":null,"issuer_url":"/issuer/0001768446","owner_cik":"0001868517","owner_name":"Morisset Valerie","owner_display_name":"Morisset Valerie","owner_url":"/insider/0001868517","role":"Officer (EVP, R&D AND CSO)","role_mark":"O","role_mark_label":"Officer (EVP, R&D AND CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D AND CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5931.0,"shares_display":"5,931","price_per_share":6.66,"price_display":"6.66","price_state":"stated","total_value":39500.46,"total_display":"39,500.46","total_whole":"39,500","shares_owned_after":444683.0,"shares_owned_after_display":"444,683","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-09","filed_date":"2024-07-11","scope":"insider"},{"id":2603476,"accession":"0001415889-24-019433","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-019433","line_url":"/filing/0001415889-24-019433#line-1","is_derivative":false,"issuer_cik":"0001768446","issuer_name":"Eliem Therapeutics, Inc.","issuer_ticker":"ELYM","issuer_name_source":null,"issuer_url":"/issuer/0001768446","owner_cik":"0001868517","owner_name":"Morisset Valerie","owner_display_name":"Morisset Valerie","owner_url":"/insider/0001868517","role":"Officer (EVP, R&D AND CSO)","role_mark":"O","role_mark_label":"Officer (EVP, R&D AND CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D AND CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12342.0,"shares_display":"12,342","price_per_share":7.06,"price_display":"7.06","price_state":"stated","total_value":87134.52,"total_display":"87,134.52","total_whole":"87,135","shares_owned_after":450614.0,"shares_owned_after_display":"450,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-05","filed_date":"2024-07-09","scope":"insider"},{"id":2370477,"accession":"0001415889-24-019147","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-019147","line_url":"/filing/0001415889-24-019147#line-2","is_derivative":false,"issuer_cik":"0001768446","issuer_name":"Eliem Therapeutics, Inc.","issuer_ticker":"ELYM","issuer_name_source":null,"issuer_url":"/issuer/0001768446","owner_cik":"0001868517","owner_name":"Morisset Valerie","owner_display_name":"Morisset Valerie","owner_url":"/insider/0001868517","role":"Officer (EVP, R&D AND CSO)","role_mark":"O","role_mark_label":"Officer (EVP, R&D AND CSO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, R&D AND CSO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":6.76,"price_display":"6.76","price_state":"stated","total_value":338000.0,"total_display":"338,000.00","total_whole":"338,000","shares_owned_after":462956.0,"shares_owned_after_display":"462,956","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-03","filed_date":"2024-07-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001768446","name":"Eliem Therapeutics, Inc.","url":"/issuer/0001768446","role":"Officer (EVP, R&D AND CSO)","n_filings":7,"first_seen":"2024-07-03","last_seen":"2024-07-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001868517","retrieved_at":"2026-08-25T06:55:02+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}